Xenetic Biosciences, Inc. Common Stock Shares Outstanding

Quick Answer

Xenetic Biosciences, Inc. reported Common Stock Shares Outstanding of 2.29 million shares for the year ending 2025.

  • Xenetic Biosciences, Inc. showed an increase of +48.6% in Common Stock Shares Outstanding from 2024 to 2025.
  • This data is from Xenetic Biosciences, Inc.'s annual report (Form 10-K), filed with the SEC on March 12, 2026.
  • XBRL data for this metric is available from 2013 to 2025 (13 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 13 years of available data (2013 to 2025), Xenetic Biosciences, Inc.'s Common Stock Shares Outstanding has declined by 98.1%.
  • Historical annual values: Fiscal year 2025: 2.29 million shares | Fiscal year 2024: 1.54 million shares | Fiscal year 2023: 1.54 million shares | Fiscal year 2022: 1.52 million shares | Fiscal year 2021: 13.44 million shares | Fiscal year 2020: 8.75 million shares | Fiscal year 2019: 6.07 million shares | Fiscal year 2018: 9.40 million shares | Fiscal year 2017: 8.72 million shares | Fiscal year 2016: 4.59 million shares | Fiscal year 2015: 4.59 million shares | Fiscal year 2014: 139.30 million shares | Fiscal year 2013: 119.89 million shares.
  • Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: